2.       Schwartz G, Quigley H. Adherence and Persistence with Glaucoma Therapy. Surv. Ophthalmol. 2008Nov;53 Suppl1:S57-68.

3.       Newman-Casey P et al. Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015. Expert Rev Ophthalmol. 2016; 11(1): 5–20

4.       Stewart WC, Chorak RP, Hunt HH, et al: Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993;116:176-81.

5.       Sheer R et al. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study. J Manag Care Spec Pharm. 2016;22(7):808-17

6.       Nakano T et al. Differences in Neuroticism Between Patients with Glaucoma Who Have Discontinued Visits to Ophthalmologists and Those Who Make Regular Visits: Implications for Adherence to Topical Glaucoma Medication. Ophthalmol Ther. 2016; 5:207–214.

7.       Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011;5:441-63.

8.        Friedman DS, Hahn SR, Gelb L, et al; Doctor-patient communication and health-related beliefs: Results from the Glaucoma Adherence and Persistency Study (GAPS). Ophthalmology. 2008; 115:1320-1327.

9.       Newman-Casey P et al. Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Ophthalmology. 2015; 122(7): 1308–1316.

10.    Slota C et al. Glaucoma patient expression of medication problems and nonadherence. Optom Vis Sci 2015; 92(5):537-43

11.    Gupta VS et al. Strategies to Improve Glaucoma Compliance Based on Cross-Sectional Response-Based Data in a Tertiary Healthcare Center: The Glauco-Jung Study. J Curr Glaucoma Pract. 2015; 9(2):38-46